Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology
Uveitis Clinical Trials
A listing of Uveitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Phoenix :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Phoenix :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Phoenix :
Study Assessing Double-masked Uveitis Treatment
Tucson :
Study Assessing Double-masked Uveitis Treatment
California
Beverly Hills :
Study Assessing Double-masked Uveitis Treatment
La Mesa :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Loma Linda :
Study Assessing Double-masked Uveitis Treatment
Long Beach :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Long Beach :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
View More »
Los Angeles :
Study Assessing Double-masked Uveitis Treatment
Mountain View :
Study Assessing Double-masked Uveitis Treatment
Mountain View : Northern California Retina Vitreous Associates Updated
TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema
Sacramento :
Study Assessing Double-masked Uveitis Treatment
San Luis Obispo :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Santa Ana :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Torrance :
Study Assessing Double-masked Uveitis Treatment
Colorado
Colorado Springs :
Study Assessing Double-masked Uveitis Treatment
Golden :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Golden :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Golden :
Study Assessing Double-masked Uveitis Treatment
Littleton :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
View More »
Littleton :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Lone Tree :
Study Assessing Double-masked Uveitis Treatment
Longmont :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Connecticut
Bridgeport :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Florida
Altamonte Springs :
Study Assessing Double-masked Uveitis Treatment
Jacksonville :
Study Assessing Double-masked Uveitis Treatment
Miami : Bascom Palmer Eye Insitute
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Miami :
Study Assessing Double-masked Uveitis Treatment
Orlando :
Study Assessing Double-masked Uveitis Treatment
View More »
Palm Beach Gardens : Bascom Palmer of the Palm Beaches
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
Pensacola :
Study Assessing Double-masked Uveitis Treatment
Sarasota :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Winter Haven :
Study Assessing Double-masked Uveitis Treatment
Georgia
Augusta :
Study Assessing Double-masked Uveitis Treatment
Illinois
Chicago : Northwestern University
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Chicago :
Study Assessing Double-masked Uveitis Treatment
Oak Park :
Study Assessing Double-masked Uveitis Treatment
Iowa
Iowa City :
Study Assessing Double-masked Uveitis Treatment
Kansas
Wichita :
Study Assessing Double-masked Uveitis Treatment
Kentucky
Edgewood : Cincinnati Eye Institute
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
Maine
Ellsworth :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Ellsworth :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Maryland
Baltimore : Wilmer Eye Institute at Johns Hopkins University
Sirolimus as Therapeutic Approach to Uveitis
Baltimore :
Study Assessing Double-masked Uveitis Treatment
Massachusetts
Boston : Ophthalmic Partners of Boston
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
Boston : Massachusetts Eye and Ear Infirmary
PEMF: an Adjunct Therapy for Anterior Uveitis
Boston :
Study Assessing Double-masked Uveitis Treatment
Cambridge :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Cambridge :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
View More »
Cambridge :
Study Assessing Double-masked Uveitis Treatment
Peabody :
Study Assessing Double-masked Uveitis Treatment
Michigan
Ann Arbor :
Study Assessing Double-masked Uveitis Treatment
Grand Rapids :
Study Assessing Double-masked Uveitis Treatment
Jackson :
Study Assessing Double-masked Uveitis Treatment
Royal Oak :
Study Assessing Double-masked Uveitis Treatment
Southfield :
Study Assessing Double-masked Uveitis Treatment
Minnesota
Edina :
Study Assessing Double-masked Uveitis Treatment
Stillwater : Associated Eye Care
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
Montana
Missoula :
Study Assessing Double-masked Uveitis Treatment
Nebraska
Lincoln :
Study Assessing Double-masked Uveitis Treatment
New Hampshire
Portsmouth :
Study Assessing Double-masked Uveitis Treatment
New Jersey
New Brunswick :
Study Assessing Double-masked Uveitis Treatment
Northfield :
Study Assessing Double-masked Uveitis Treatment
Teaneck :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Teaneck :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Teaneck :
Study Assessing Double-masked Uveitis Treatment
View More »
Toms River :
Study Assessing Double-masked Uveitis Treatment
Vauxhall :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Vauxhall :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
New York
Albany :
Study Assessing Double-masked Uveitis Treatment
New York :
Study Assessing Double-masked Uveitis Treatment
Orchard Park :
Study Assessing Double-masked Uveitis Treatment
Rochester :
Study Assessing Double-masked Uveitis Treatment
Slingerlands :
Study Assessing Double-masked Uveitis Treatment
North Carolina
Belmont :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Belmont :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Southern Pines :
Study Assessing Double-masked Uveitis Treatment
Winston-Salem :
Study Assessing Double-masked Uveitis Treatment
Ohio
Beachwood :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Beachwood :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Cleveland :
Study Assessing Double-masked Uveitis Treatment
Oregon
Pennsylvania
Camp Hill :
Study Assessing Double-masked Uveitis Treatment
Huntingdon Valley :
Study Assessing Double-masked Uveitis Treatment
Johnstown :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Pittsburgh :
Study Assessing Double-masked Uveitis Treatment
Reading :
Study Assessing Double-masked Uveitis Treatment
View More »
West Mifflin :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
West Mifflin :
Study Assessing Double-masked Uveitis Treatment
South Carolina
Columbia :
Study Assessing Double-masked Uveitis Treatment
Ladson :
Study Assessing Double-masked Uveitis Treatment
South Dakota
Rapid City :
Study Assessing Double-masked Uveitis Treatment
Tennessee
Knoxville :
Study Assessing Double-masked Uveitis Treatment
Texas
Dallas : Metroplex Clinical Research Center
A randomized, double-masked, placebo-controlled study of the safety and efficacy of gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan-uveitis
View More »
Arlington :
Study Assessing Double-masked Uveitis Treatment
Austin :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Austin :
Study Assessing Double-masked Uveitis Treatment
Dallas :
Study Assessing Double-masked Uveitis Treatment
Fort Worth :
Study Assessing Double-masked Uveitis Treatment
Houston :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Houston :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
Houston :
Study Assessing Double-masked Uveitis Treatment
McAllen :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
McAllen :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
San Antonio :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
San Antonio :
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
San Antonio :
Study Assessing Double-masked Uveitis Treatment
Utah
Salt Lake City :
Study Assessing Double-masked Uveitis Treatment
Vermont
Burlington :
Study Assessing Double-masked Uveitis Treatment
Virginia
Norfolk :
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
Richmond :
Study Assessing Double-masked Uveitis Treatment
Wisconsin
Milwaukee :
Study Assessing Double-masked Uveitis Treatment
Argentina
Buenos Aires :
Study Assessing Double-masked Uveitis Treatment
Capital Federal :
Study Assessing Double-masked Uveitis Treatment
Derqui-pilar :
Study Assessing Double-masked Uveitis Treatment
Olivos :
Study Assessing Double-masked Uveitis Treatment
Pilar :
Study Assessing Double-masked Uveitis Treatment
Austria
Graz :
Study Assessing Double-masked Uveitis Treatment
Klagenfurt :
Study Assessing Double-masked Uveitis Treatment
Brazil
Americana :
Study Assessing Double-masked Uveitis Treatment
Araraquara :
Study Assessing Double-masked Uveitis Treatment
Cali :
Study Assessing Double-masked Uveitis Treatment
Londrina :
Study Assessing Double-masked Uveitis Treatment
Recife :
Study Assessing Double-masked Uveitis Treatment
View More »
Rio de Janeiro :
Study Assessing Double-masked Uveitis Treatment
Sao Jose de Rio Preto :
Study Assessing Double-masked Uveitis Treatment
Sao Paulo :
Study Assessing Double-masked Uveitis Treatment
Sorocaba :
Study Assessing Double-masked Uveitis Treatment
Chile
Santiago :
Study Assessing Double-masked Uveitis Treatment
Colombia
Bogota :
Study Assessing Double-masked Uveitis Treatment
Medellin :
Study Assessing Double-masked Uveitis Treatment
Estonia
Tartu : Tartu University Clinics
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
France
Grenoble :
Study Assessing Double-masked Uveitis Treatment
Lyon :
Study Assessing Double-masked Uveitis Treatment
Marseille :
Study Assessing Double-masked Uveitis Treatment
Nantes :
Study Assessing Double-masked Uveitis Treatment
Paris :
A Long-Term Safety Study of OZURDEX® in Clinical Practice
View More »
Paris : Hospital of necker Enfants malades
Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Paris :
Study Assessing Double-masked Uveitis Treatment
Germany
Berlin :
Study Assessing Double-masked Uveitis Treatment
Dessau Rosslau :
Study Assessing Double-masked Uveitis Treatment
Freiburg :
Study Assessing Double-masked Uveitis Treatment
Heidelberg : Universitätsklinikum Heidelberg, Interdisziplinäres Uveitiszentrum
Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Heidelberg :
Study Assessing Double-masked Uveitis Treatment
View More »
Kiel :
Study Assessing Double-masked Uveitis Treatment
Koln :
Study Assessing Double-masked Uveitis Treatment
Munchen :
Study Assessing Double-masked Uveitis Treatment
Ulm :
A Long-Term Safety Study of OZURDEX® in Clinical Practice
India
Ahmedabad :
Study Assessing Double-masked Uveitis Treatment
Bangalore :
Study Assessing Double-masked Uveitis Treatment
Bhubaneswar, Orissa :
Study Assessing Double-masked Uveitis Treatment
Chennai :
Study Assessing Double-masked Uveitis Treatment
Hyderabad :
Study Assessing Double-masked Uveitis Treatment
View More »
Kolkata :
Study Assessing Double-masked Uveitis Treatment
Madurai :
Study Assessing Double-masked Uveitis Treatment
New Delhi :
Study Assessing Double-masked Uveitis Treatment
Noida :
Study Assessing Double-masked Uveitis Treatment
Iran, Islamic Republic of
Tehran : Rheumatology Research Center, Behcet's Disease Unit (Shariati Hospital)
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Israel
Afula :
Study Assessing Double-masked Uveitis Treatment
Beer Sheva :
Study Assessing Double-masked Uveitis Treatment
Haifa :
Study Assessing Double-masked Uveitis Treatment
Jerusalem :
Study Assessing Double-masked Uveitis Treatment
Petach Tikva :
Study Assessing Double-masked Uveitis Treatment
View More »
Ramat Gan :
Study Assessing Double-masked Uveitis Treatment
Rehovot :
Study Assessing Double-masked Uveitis Treatment
Tel Aviv :
Study Assessing Double-masked Uveitis Treatment
Italy
Bologna :
Study Assessing Double-masked Uveitis Treatment
Brescia :
Study Assessing Double-masked Uveitis Treatment
Firenze :
Study Assessing Double-masked Uveitis Treatment
Milano :
Study Assessing Double-masked Uveitis Treatment
Padova :
Study Assessing Double-masked Uveitis Treatment
View More »
Pisa :
Study Assessing Double-masked Uveitis Treatment
Japan
Bunkyo-ku :
Study Assessing Double-masked Uveitis Treatment
Mitaka :
Study Assessing Double-masked Uveitis Treatment
Osaka :
Study Assessing Double-masked Uveitis Treatment
Sapporo :
Study Assessing Double-masked Uveitis Treatment
Sendai :
Study Assessing Double-masked Uveitis Treatment
View More »
Shinijuku-ku :
Study Assessing Double-masked Uveitis Treatment
Netherlands
Nijmegen :
Study Assessing Double-masked Uveitis Treatment
Peru
La Libertad :
Study Assessing Double-masked Uveitis Treatment
Lima :
Study Assessing Double-masked Uveitis Treatment
Trujillo :
Study Assessing Double-masked Uveitis Treatment
Poland
Lodz :
Study Assessing Double-masked Uveitis Treatment
Lublin :
Study Assessing Double-masked Uveitis Treatment
Poznan :
Study Assessing Double-masked Uveitis Treatment
Wroclaw :
Study Assessing Double-masked Uveitis Treatment
Spain
Alicante :
Study Assessing Double-masked Uveitis Treatment
Leon :
Study Assessing Double-masked Uveitis Treatment
Madrid :
Study Assessing Double-masked Uveitis Treatment
Santiago de Compostela :
Study Assessing Double-masked Uveitis Treatment
Torrevieja :
Study Assessing Double-masked Uveitis Treatment
Taiwan
Taoyuan County : CGMH
Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
Turkey
Ankara :
Study Assessing Double-masked Uveitis Treatment
Istanbul :
Study Assessing Double-masked Uveitis Treatment
Izmir :
Study Assessing Double-masked Uveitis Treatment
United Kingdom
Aberdeen :
Study Assessing Double-masked Uveitis Treatment
Belfast :
Study Assessing Double-masked Uveitis Treatment
Birmingham :
Study Assessing Double-masked Uveitis Treatment
Bradford :
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Bradford :
Study Assessing Double-masked Uveitis Treatment
View More »
Bristol :
Study Assessing Double-masked Uveitis Treatment
Guildford :
Study Assessing Double-masked Uveitis Treatment
London :
Study Assessing Double-masked Uveitis Treatment
London : Moorfields Eye Hospital NHSFT Research and Treatment Centre
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
